GUERISON forays into India’s ophthalmology market

GUERISON, a global pharma player with a focus on ophthalmology business has finally set up its footprints in India’s ophthalmology market (north, east and west region of India) with the launch of its new range of 25 allopathy ophthalmic products including GUERIMOD, GUERIPRED, BIMATO MST etc for curing various diseases related to eyes.

A company statement informed, “The multivitamin from GUERISON is GUERIHERB which is pure herbal with no side effects and the allopathic antioxidants from GUERISON is GUERIOX which have done wonders with the patients. The product range is available with Amazon and Tata 1mg based on prescription. The other range of products are introduced which helps to cure dry eye with post operative eye drops.”

It further stated, “The company provides a range of allopathic medicines, dry eye supplements, and a complete range of eye drops to treat various corneal and retinal problems. The manufacturing facility is fully compliant with top-notch technology and has obtained accreditation from the WHO-GMP and ISO, as well as several other countries across the world. The company aims and plans to create new and innovative product ranges that meet the needs of doctors, surgeons, and patients.”

Chaandan Munjaal, CEO – GUERISON India stated, “We have allocated resources for quality products, innovative and attractive pyramid packaging, man power training/grooming and conducting eye check-up camps as CSR. As manpower, we here develop good presentable, trained humans with a sense of responsibility and not just trained machines like humans.